Pill Takes the Bite Out of Viper Venom
A preexisting drug could buy time for snakebite treatment -- Read more on ScientificAmerican.com
Fluoridated Water Criticized as Socialized Medicine
Originally published in February 1955 -- Read more on ScientificAmerican.com
Fauci Optimistic About COVID-19 Vaccines, Though Immunity Unknowns Complicate Development
Teams are starting to test vaccines using messenger RNA or chimpanzee cold viruses to inoculate humans. Will their benefits last? -- Read more on ScientificAmerican.com
Concerns about Waning COVID-19 Immunity Are Likely Overblown
The decline seen in some studies is normal, experts say. But scientists must wait to see whether infection confers long-term protection -- Read more on ScientificAmerican.com
Vaccine Trials Should Reflect America’s Diversity
Racial minorities and those with underlying health conditions may be at a greater risk from coronavirus infection, but have historically been less likely to be included in clinical trials -- Read more on ScientificAmerican.com
Experimental Blood Test Detects Cancer up to Four Years before Symptoms Appear
The assay looks for stomach, esophageal, colorectal, lung and liver malignancies -- Read more on ScientificAmerican.com
Viral Learning Curve
Drug manufacturers are racing to create a protective measure against coronavirus without destroying the patient’s immune system -- Read more on ScientificAmerican.com
COVID-19 Is Forcing Us to Rethink Clinical Trials for Cancer Treatments
Participation rates were already low, but the pandemic threatens to drive them even lower -- Read more on ScientificAmerican.com
Vaccinations Have Sharply Declined Nationwide during the COVID-19 Pandemic
Rates of childhood immunization have fallen across the U.S., raising the risk of vaccine-preventable disease outbreaks -- Read more on ScientificAmerican.com
Hospitals Experiment with COVID-19 Treatments, Balancing Hope and Evidence
With little data on what works and what doesn’t, doctors trade tips and argue about risks -- Read more on ScientificAmerican.com
Common Steroid Could Be Cheap and Effective Treatment for Severe COVID-19
The results of a trial that found dexamethasone reduced the risk of death in extremely ill coronavirus patients have yet to be published, but some doctors are already embracing them -- Read more on ScientificAmerican.com
A Visual Guide to the SARS-CoV-2 Coronavirus
What scientists know about the inner workings of the pathogen that has infected the world -- Read more on ScientificAmerican.com
A Visual Guide to the SARS-CoV-2 Coronavirus
What scientists know about the inner workings of the pathogen that has infected the world -- Read more on ScientificAmerican.com
Coronavirus Antibody Therapies Raise Hopes–and Skepticism
Some experts caution we should temper our expectations about the much-touted approach -- Read more on ScientificAmerican.com
COVID-19 Vaccine Developers Search for Antibodies That ‘First Do No Harm’
Biotechs and pharma want to protect patients without triggering immune system havoc -- Read more on ScientificAmerican.com
Early Coronavirus Immunity Data Fuel Promise for a Vaccine
Researchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good news -- Read more on ScientificAmerican.com